On the GS call (happening now) Dan Welch indicated top-line results of 1B could come at October Liver Disease meeting (perhaps just the initial cohort). Other option is December meeting (didn't catch witch one).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.